RavenQuest BioMed Inc. (RVVQF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerRavenQuest BioMed Inc. (RVVQF) trades at $0.00001. RavenQuest BioMed Inc. is a Canadian cannabis company focused on production, management services, consulting, and R&D. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for RVVQF: RVVQF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
RavenQuest BioMed Inc. (RVVQF) Healthcare & Pipeline Overview
RavenQuest BioMed Inc. is a Canadian cannabis company involved in cannabis production, consulting, and R&D, operating in the evolving specialty and generic drug manufacturing sector. With a focus on cultivation and sales, RavenQuest markets its products under the Lore Cannabis and Bloomera brands, navigating the complexities of the cannabis industry.
What Is the Investment Thesis for RVVQF?
RavenQuest BioMed Inc. presents a speculative investment opportunity within the cannabis sector. The company's focus on both consulting services and cannabis cultivation offers diversified revenue streams. However, the company's negative P/E ratio of -0.00 and a significantly negative profit margin of -2423.9% indicate substantial financial challenges. The gross margin of 63.7% suggests potential profitability in its core operations, but overall financial performance needs improvement. Upcoming catalysts include potential regulatory changes in the cannabis industry and expansion of its product lines under the Lore Cannabis and Bloomera brands. Investors should carefully consider the risks associated with OTC-listed companies and the volatile nature of the cannabis market.
Based on FMP financials and quantitative analysis
RVVQF Key Highlights
Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E Ratio of -0.00 reflects the company's current lack of profitability.
- Profit Margin of -2423.9% highlights significant operational inefficiencies and high costs.
- Gross Margin of 63.7% suggests potential for profitability if operational costs are managed effectively.
- Beta of -0.23 indicates a low correlation with the overall market, potentially offering some downside protection during market downturns.
Who Are RVVQF's Competitors?
RVVQF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AVTBF Avant Brands Inc. | $0.37 | +4.14% | $5.48M | — |
| BBRRF Blueberries Medical Corp. | $0.01 | +17.31% | $5.89M | — |
| CPIVF Captiva Verde Wellness Corp. | $0.06 | 0.00% | $19.2M | — |
| MVMDF Mountain Valley MD Holdings Inc. | $0.04 | +3.94% | $14.1M | — |
| AKAN Akanda Corp. | $1.89 | -4.55% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.81% | $5.94M | — |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.36 | +35.40% | $7.59M | — |
| BFRI Biofrontera Inc. | $0.91 | -10.34% | $13.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RVVQF's Key Strengths?
Established brands (Lore Cannabis and Bloomera).
- Diversified revenue streams (cultivation, consulting).
- Expertise in cannabis cultivation and management.
- Strong gross margin (63.7%).
What Are RVVQF's Weaknesses?
Negative profit margin (-2423.9%).
- Limited market capitalization ($0.00B).
- OTC listing indicates higher risk.
- Dependence on evolving cannabis regulations.
What Are the Key Risks for RVVQF?
Financial-distress signal — its Altman Z-Score of -4.15 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis industry.
- Fluctuations in cannabis prices.
- Negative publicity and reputational damage.
- Dependence on evolving cannabis regulations.
- Limited financial resources and negative profitability.
What Are RVVQF's Competitive Advantages?
- Brand recognition through Lore Cannabis and Bloomera brands.
- Expertise in cannabis cultivation and management.
- Established consulting services business.
What Does RVVQF Do?
RavenQuest BioMed Inc., incorporated in 1987 and rebranded in September 2017, is a Canadian cannabis company headquartered in Vancouver. The company operates in the burgeoning cannabis industry, focusing on cannabis production, management services, consulting, and specialized research and development activities. RavenQuest BioMed operates through two primary segments: Consulting Business, which provides expertise and support to other cannabis businesses, and Cultivation and Sale of Medical Cannabis, which involves the production and distribution of cannabis products. The company's products are marketed under the brand names Lore Cannabis and Bloomera, targeting different segments within the cannabis market. RavenQuest's strategic focus includes expanding its cultivation capabilities and developing innovative cannabis products. The company aims to establish a strong presence in the Canadian cannabis market and potentially expand into international markets as regulations evolve. RavenQuest BioMed Inc. continues to adapt to the changing regulatory landscape and market dynamics within the cannabis industry.
What Products and Services Does RVVQF Offer?
- Cultivates and sells medical cannabis.
- Provides management services to other cannabis companies.
- Offers consulting services in the cannabis industry.
- Engages in specialized research and development activities.
- Markets cannabis products under the Lore Cannabis brand.
- Markets cannabis products under the Bloomera brand.
How Does RVVQF Make Money?
- Generates revenue through the cultivation and sale of medical cannabis products.
- Earns fees by providing management and consulting services to other cannabis businesses.
- Invests in research and development to create new cannabis products and technologies.
What Industry Does RVVQF Operate In?
RavenQuest BioMed Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing demand for both medical and recreational cannabis products. RavenQuest competes with other cannabis producers and consulting firms, including AVTBF (Avant Brands Inc.), BBRRF (BevCanna Enterprises Inc.), CANN (Cronos Group Inc.), CPIVF (Canopy Rivers Inc.), and MVMDF (MediPharm Labs Corp.). The industry is subject to evolving regulations and licensing requirements, impacting market entry and operational costs.
Who Are RVVQF's Key Customers?
- Medical cannabis patients.
- Recreational cannabis consumers (where legally permitted).
- Other cannabis companies seeking management and consulting services.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on assets is -80.8%, showing how much profit it generates from its asset base. A current ratio of 1.14 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
RavenQuest BioMed Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO David Allen Cross. RVVQF has traded publicly since 2018.
Financial Health
RavenQuest BioMed Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -4.15 places it in the distress zone, a signal of elevated financial risk.
RVVQF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
RVVQF Latest News
No recent news available for RVVQF.
RVVQF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RVVQF.
Price Targets
Wall Street price target analysis for RVVQF.
RVVQF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RVVQF; grades run from A+ (80-100) to F (below 30).
Leadership: David Allen Cross
CEO
David Allen Cross serves as the CEO of RavenQuest BioMed Inc. His background includes experience in corporate management and strategic development within emerging industries. Cross has been involved in guiding companies through periods of growth and transformation, with a focus on optimizing operational efficiency and market positioning. His expertise spans various sectors, including resource management and technology, bringing a diverse perspective to the cannabis industry.
Track Record: Under David Allen Cross's leadership, RavenQuest BioMed Inc. has focused on expanding its cannabis cultivation and consulting services. Key milestones include the development of the Lore Cannabis and Bloomera brands and efforts to navigate the evolving regulatory landscape in Canada. Cross has emphasized strategic partnerships and product innovation to drive growth and market share.
RVVQF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that RavenQuest BioMed Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as exchange-listed companies. Investing in OTC Other stocks carries significant risks due to the potential for limited information and higher volatility compared to stocks listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with distressed financials or those that are newly formed and have yet to establish a strong track record.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Lower trading volume and liquidity.
- Higher price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's regulatory filings and compliance history.
- Evaluate the company's liquidity and trading volume.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established brands (Lore Cannabis and Bloomera).
- Active in the cannabis industry since 2017.
- Operations in Canada.
- Presence of a CEO (David Allen Cross).
RavenQuest BioMed Inc. Healthcare Stock: Key Questions Answered
What do analysts say about RVVQF stock?
As of March 16, 2026, there is limited analyst coverage specifically for RVVQF stock due to its OTC listing and micro-cap status.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- Financial data may not be up-to-date.